Voximetry continues its momentum with hiring of Chief Executive Officer Dr. Sue Wallace.
MADISON, Wis.– Voximetry Inc., a Madison, Wisconsin-based Healthtech software company with unique technology for personalized Radiopharmaceutical Therapy (RPT) planning, has announced the permanent appointment of Susan L. Wallace, PhD as Chief Executive Officer.
Voximetry’s Torch™ software platform implements proprietary Monte Carlo algorithms on high-speed Graphic Processing Units (GPUs). This voxel-based dosimetry enables physicians to effectively treat metastatic disease without exceeding toxicity thresholds of critical organs.
Voximetry’s Chairman, Chief Science Officer & Co-founder, Dr. Bryan Bednarz, stated, “With the appointment of Dr. Wallace, we have locked in key leadership to accelerate our time to commercial launch. Sue’s extensive global experience leading radiation-based medical imaging and therapy businesses provides the Company with important insight into market dynamics and alliances. We are confident this addition will not only accelerate our time to market but also improve the market adoption of dosimetry and our Torch offerings.”
Dr. Joe Grudzinski, Voximetry’s Chief Innovation Officer & Co-founder, added, “Our unique algorithms developed at the University of Wisconsin represent the new frontier of therapy planning for RPT. By adapting them to GPUs and providing widespread commercial access, we’re providing important fuel to ignite and feed the $5B market for RPT that has been projected over the next 5 years. We’re excited to have a new leader who understands the potential from day one.”
Dr. Wallace has spent her entire career advancing innovative radiation science technologies. Sue received her Bachelor of Science degree in Chemistry from the University of Wisconsin in Milwaukee. She went on to earn a Master of Science degree in Nuclear Chemistry and a Doctorate degree in PET Radiopharmaceutical Chemistry from Washington University in St. Louis. In addition, she was trained in Six Sigma methodology during her tenure at GE Healthcare and is an experienced Six Sigma Master Black Belt. Sue has held both commercial and operational senior leadership positions in large global Healthtech companies including GE, Philips, Cardinal Health and Accuray. She also spent many years working with early stage and pre-revenue small companies to accelerate product development and prepare for commercial launch.
About Voximetry Inc.: Based in Madison, Wisconsin, Voximetry is a is an early-stage Healthtech company specializing in commercialization of complex algorithms on high speed Graphic Processing Units (GPUs). Currently focused on radiation transport science, Voximetry is advancing patient-specific treatment planning in advanced stage cancer patients. Voximetry leverages intellectual property developed at the University of Wisconsin – Madison, which has a rich history of fostering successful biotechnology companies. Torch has not yet been submitted to FDA for review of its Indications for Use and is therefore NOT suitable for clinical use.